|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Stock-based compensation | |||||
| Depreciation and amortization | |||||
| Deferred income taxes | |||||
| Net accretion of available-for-sale securities | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable, net | |||||
| Inventory | |||||
| Prepaid expenses and other assets | |||||
| Accounts payable | |||||
| Accrued liabilities | |||||
| Deferred revenue | |||||
| Other long-term liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Purchases of property and equipment | |||||
| Purchases of marketable securities | |||||
| Sales of marketable securities | |||||
| Maturities of marketable securities | |||||
| Net cash used in investing activities | |||||
| Financing activities: | |||||
| Proceeds from common stock issuances related to employee benefit plans | |||||
| Repurchases of common stock | |||||
| Payments related to financing arrangements | |||||
| Net cash provided by (used in) financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase (decrease) in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosures of cash flow information: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Non-cash investing activities: | |||||
| Changes in accounts payable and accrued liabilities related to purchases of property and equipment | |||||
Loading...